Innate Pharma
IPHA
#8366
Rank
NZ$0.28 B
Marketcap
$3.32
Share price
0.00%
Change (1 day)
-19.83%
Change (1 year)

Earnings for Innate Pharma (IPHA)

Earnings in 2023: -NZ$14.04 Million

According to Innate Pharma 's latest financial reports the company's current earnings are NZ$57.37 Million. In 2023 the company made an earning of -NZ$14.04 Million, an increase over its 2022 earnings that were of -NZ$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Innate Pharma from 2005 to 2023

Annual earnings

Year Earnings Change
2023-NZ$14.04 Million-86.54%
2022-NZ$0.11 Billion20.74%
2021-NZ$86.37 Million4951.09%
2020-NZ$1.71 Million-111.57%
2019NZ$14.78 M183.46%
2018NZ$5.21 M-105.4%
2017-NZ$96.61 Million-523.25%
2016NZ$22.82 M-285.64%
2015-NZ$12.3 Million-69.31%
2014-NZ$40.07 Million498.29%
2013-NZ$6.7 Million-5.62%
2012-NZ$7.1 Million-53.32%
2011-NZ$15.21 Million-50.1%
2010-NZ$30.47 Million-13.3%
2009-NZ$35.14 Million26.36%
2008-NZ$27.81 Million27.35%
2007-NZ$21.84 Million63.33%
2006-NZ$13.37 Million9.81%
2005-NZ$12.18 Million